These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 19821528

  • 1. Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice.
    Osawa Y, Seki E, Adachi M, Suetsugu A, Ito H, Moriwaki H, Seishima M, Nagaki M.
    Hepatology; 2010 Jan; 51(1):237-45. PubMed ID: 19821528
    [Abstract] [Full Text] [Related]

  • 2. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
    Hubel E, Saroha A, Park WJ, Pewzner-Jung Y, Lavoie EG, Futerman AH, Bruck R, Fishman S, Dranoff JA, Shibolet O, Zvibel I.
    Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
    [Abstract] [Full Text] [Related]

  • 3. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression.
    Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ.
    Hepatology; 2003 Nov; 38(5):1188-98. PubMed ID: 14578857
    [Abstract] [Full Text] [Related]

  • 4. Kupffer cells abrogate cholestatic liver injury in mice.
    Gehring S, Dickson EM, San Martin ME, van Rooijen N, Papa EF, Harty MW, Tracy TF, Gregory SH.
    Gastroenterology; 2006 Mar; 130(3):810-22. PubMed ID: 16530521
    [Abstract] [Full Text] [Related]

  • 5. The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury.
    Chan CC, Cheng LY, Lin CL, Huang YH, Lin HC, Lee FY.
    Mol Nutr Food Res; 2011 Dec; 55(12):1841-9. PubMed ID: 22086758
    [Abstract] [Full Text] [Related]

  • 6. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL.
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [Abstract] [Full Text] [Related]

  • 7. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
    Tamaki N, Hatano E, Taura K, Tada M, Kodama Y, Nitta T, Iwaisako K, Seo S, Nakajima A, Ikai I, Uemoto S.
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
    [Abstract] [Full Text] [Related]

  • 8. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
    Wang H, Vohra BP, Zhang Y, Heuckeroth RO.
    Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
    [Abstract] [Full Text] [Related]

  • 9. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
    Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ.
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
    [Abstract] [Full Text] [Related]

  • 10. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment.
    Ramm GA, Shepherd RW, Hoskins AC, Greco SA, Ney AD, Pereira TN, Bridle KR, Doecke JD, Meikle PJ, Turlin B, Lewindon PJ.
    Hepatology; 2009 Feb; 49(2):533-44. PubMed ID: 19115220
    [Abstract] [Full Text] [Related]

  • 11. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice.
    Abe T, Arai T, Ogawa A, Hiromatsu T, Masuda A, Matsuguchi T, Nimura Y, Yoshikai Y.
    Hepatology; 2004 Aug; 40(2):414-23. PubMed ID: 15368446
    [Abstract] [Full Text] [Related]

  • 12. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
    Li Z, Mizuno S, Nakamura T.
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bone marrow cell transplantation is associated with fibrogenic cells apoptosis during hepatic regeneration in cholestatic rats.
    Nunes de Carvalho S, da Cunha Lira D, Costa Cortez EA, de Andrade DC, Thole AA, Stumbo AC, de Carvalho L.
    Biochem Cell Biol; 2013 Apr; 91(2):88-94. PubMed ID: 23527637
    [Abstract] [Full Text] [Related]

  • 15. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
    Wang H, Zhang Y, Heuckeroth RO.
    Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms.
    Sakamoto K, Khai NC, Wang Y, Irie R, Takamatsu H, Matsufuji H, Kosai KI.
    Int J Mol Med; 2016 Dec; 38(6):1673-1682. PubMed ID: 27779646
    [Abstract] [Full Text] [Related]

  • 19. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
    Jang JH, Rickenbacher A, Humar B, Weber A, Raptis DA, Lehmann K, Stieger B, Moritz W, Soll C, Georgiev P, Fischer D, Laczko E, Graf R, Clavien PA.
    Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.